검색어 입력폼

TSL 종양용해증후군PPT

저작시기 2011.02 |등록일 2013.04.29 파워포인트파일MS 파워포인트 (ppt) | 22페이지 | 가격 3,500원

목차

1. Pathophysiology
2. Clinical Findings
3. Medical Management
4. Case Study
5. Nursing Management
6. Conclusion

본문내용

Pathophysiology
TLS occurs from the rapid release of intracellular components during cell death.
When cancer cells are destroyed by chemotherapy or radiation, they spill their intracellular components into the bloodstream, causing an influx of potassium, phosphorus, and nucleic acid

Hyperuricemia occurs when the liver converts nucleic acids into uric acid.
hypocalcemia develops as serum calcium binds to elevated amounts of phosphorus within the bloodstream.

<중 략>

Ⅱ. Treatment Measures
Hyperkalemia : sodium polystyrene sulfonate, diuretics, IV glucose and insulin infusions,
IV calcium gluconate, dialysis
Hyperphosphatemia and hypocalcemia
: IV 10% calcium gluconate,
oral phosphate binders,
dietary restriction of phosphorus intake,
dialysis

참고 자료

없음
다운로드 맨위로